These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
109 related items for PubMed ID: 14301447
1. INTRODUCTION OF MERCURY INTO THE ACTIVE SITE OF CHYMOTRYPSIN P-CHLOROMERCURIBENZENESULFONYL-CHYMOTRYPSIN. RIZOK D, KALLOS J. Biochem Biophys Res Commun; 1965 Feb 17; 18():478-81. PubMed ID: 14301447 [No Abstract] [Full Text] [Related]
2. STUDIES ON CYCLOSERINE-CATALYZED REACTIONS. VISWANATHA T. Proc Natl Acad Sci U S A; 1963 Nov 17; 50(5):967-74. PubMed ID: 14082364 [No Abstract] [Full Text] [Related]
3. VARIATION OF THE CONFORMATION OF THE ACTIVE SITE OF ALPHA-CHYMOTRYPSIN WITH HYDROGEN ION CONCENTRATION. PLATT A, NIEMANN C. Proc Natl Acad Sci U S A; 1963 Nov 17; 50(5):817-21. PubMed ID: 14082345 [No Abstract] [Full Text] [Related]
6. AN ISOMORPHOUS HEAVY ATOM SUBSTITUTION AT THE ACTIVE SITE OF GAMMA-CHYMOTRYPSIN. SIGLER PB, SKINNER HC, COULTER CL, KALLOS J, BRAXTON H, DAVIES DR. Proc Natl Acad Sci U S A; 1964 Jun 17; 51(6):1146-51. PubMed ID: 14215636 [No Abstract] [Full Text] [Related]
7. SULFONYL FLUORIDES AS INHIBITORS OF ESTERASES. 3. IDENTIFICATION OF SERINE AS THE SITE OF SULFONYLATION IN PHENYLMETHANESULFONYL ALPHA-CHYMOTRYPSIN. GOLD AM. Biochemistry; 1965 May 17; 4():897-901. PubMed ID: 14337707 [No Abstract] [Full Text] [Related]
10. On the interaction of the active side of alpha-chymotrypsin with chromophores: proflavin binding and enzyme conformation during catalysis. Bernhard SA, Lee BF, Tashjian ZH. J Mol Biol; 1966 Jul 17; 18(3):405-20. PubMed ID: 5966295 [No Abstract] [Full Text] [Related]
12. Acyl derivatives of alpha-chymotrypsin. Oliver RW, Viswanatha T, Whish WJ. Biochem Biophys Res Commun; 1967 Apr 07; 27(1):107-11. PubMed ID: 6048234 [No Abstract] [Full Text] [Related]
13. A hydrocarbon-water model for the formation of the enzyme-inhibitor complex in the case of alpha-chymotrypsin. Wildnauer R, Canady WJ. Biochemistry; 1966 Sep 07; 5(9):2885-92. PubMed ID: 5961875 [No Abstract] [Full Text] [Related]
14. The alpha-chymotrypsin-catalysed hydrolysis of 4-cis-benzylidene-2-oxazolin-5-one. Absence of evidence for N-O transfer. De Jersey J, Zerner B. Biochem Biophys Res Commun; 1967 Jul 21; 28(2):173-8. PubMed ID: 6040375 [No Abstract] [Full Text] [Related]
16. The effect of sample viscosity on the deacylation of p-fluoro-trans-cinnamoylchymotrypsin. Gerig JT, McLeod RS. Biochim Biophys Acta; 1977 Dec 08; 485(2):402-5. PubMed ID: 922020 [Abstract] [Full Text] [Related]
17. Reactivity of active sites of chymotrypsin suspended in an organic medium. Dastoli FR, Musto NA, Price S. Arch Biochem Biophys; 1966 Jul 08; 115(1):44-7. PubMed ID: 5966525 [No Abstract] [Full Text] [Related]
18. An x-ray diffraction study of inhibited derivatives of alpha-chymotrypsin. Sigler PB, Jeffery BA, Matthews BW, Blow DM. J Mol Biol; 1966 Jan 08; 15(1):175-92. PubMed ID: 5912039 [No Abstract] [Full Text] [Related]
19. Irreversible enzyme inhibitors. CXLV. Proteolytic enzymes. 8. Active-site-directed irreversible inhibitors of alpha-chymotrypsin derived from alpha-(2-carboxy-4-chlorophenoxy)acetamide bearing a terminal sulfonyl fluoride. Baker BR, Hurlbut JA. J Med Chem; 1969 Jan 08; 12(1):118-22. PubMed ID: 5763006 [No Abstract] [Full Text] [Related]
20. Irreversible enzyme inhibitors. CXIV. Proteolytic enzymes. IV. Additional active-site-directed irreversible inhibitors of alpha-chymotrypsin derived from phenoxyacetamides bearing a terminal sulfonyl fluoride. Baker BR, Hurlbut JA. J Med Chem; 1968 Mar 08; 11(2):241-5. PubMed ID: 5654209 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]